CCG
AGN

Cypress Capital Group’s Allergan plc AGN Stock Holding History

Cypress Capital Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,341
Closed -$225K – 253
2019
Q2 		$225K Buy
+1,341
New +$186K 0.04% 224
2018
Q2 		– Sell
-1,467
Closed -$247K – 237
2018
Q1 		$247K Buy
+1,467
New +$246K 0.05% 197

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cypress Capital Group's AGN Position: Q3 2019 in Review

Cypress Capital Group sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 1,341 shares — an estimated $225K sold.

Cypress Capital Group first reported a position in AGN in Q1 2018 and held it in 2 quarters. The position peaked at $247K in Q1 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Cypress Capital Group reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Cypress Capital Group sold 1,341 Allergan plc shares in Q3 2019, an estimated $225K.
  • Cypress Capital Group first reported a position in Allergan plc in Q1 2018 and held it in 2 quarters.
  • Cypress Capital Group's Allergan plc position peaked at $247K in Q1 2018.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Cypress Capital Group's 13F filing for Q3 2019, filed 10 Oct 2019.